Reuters logo
1 年前
BRIEF-AstraZeneca announces results from SYMBICORT study
2016年8月31日 / 晚上9点07分 / 1 年前

BRIEF-AstraZeneca announces results from SYMBICORT study

Aug 31 (Reuters) - AstraZeneca Plc

* SYMBICORT demonstrated comparable risk of serious asthma-related events and lower risk of asthma exacerbations compared to Budesonide alone

* Shared results with FDA and will soon be discussing next steps in line with post-marketing requirements Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below